Banco Bilbao Vizcaya Argentaria BBVA
$25.05 −$0.50 (-1.96%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $25.05 0.00%
Open$25.18
Prev close$25.55
Day range$25.04 – $25.50
Volume2.38M
Market cap$137.77B
P/E (TTM)11.2
Dividend yield4.19%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€10.91B+19.9% YoY
Net profit€3.20B+20.3% YoY
Diluted EPS€0.52+23.8% YoY
Free cash flow€3.31B+145.0% YoY
Operating cash flow€4.01B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin25.2%
Return on equity19.4%
Return on assets1.2%
Liabilities / assets93.7%
Cash & investments€107.95B
Total debt€110.87B
Net cash (debt)-€2.93B
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Operating Revenue | €10.91B | €11.18B | €10.65B | €39.42B | €9.80B |
| Net Interest Income | €8.08B | €7.63B | €7.54B | €26.28B | €7.03B |
| -Interest Income | €8.08B | €16.51B | €7.54B | €58.35B | €7.03B |
| Non-Interest Income | €2.84B | €3.55B | €3.12B | €13.14B | €2.76B |
| -Fees and Commissions | €2.34B | €2.32B | €2.26B | €8.21B | €2.15B |
| -Trading Gain Loss | €596.00M | €517.00M | €915.00M | €2.26B | €694.00M |
| -Other Non-Interest Income | -€98.00M | €108.00M | -€56.00M | €689.00M | -€78.00M |
| -Gain Loss on Sale of Assets | €0.00 | €185.00M | €0.00 | €619.00M | €0.00 |
| Credit Losses Provision | -€1.95B | -€1.67B | -€1.82B | -€6.21B | -€1.75B |
| Non-Interest Expense | €4.21B | €4.67B | €4.11B | €16.10B | €4.11B |
| Selling and Admin Expenses | €3.73B | €3.54B | €3.63B | €12.59B | €3.58B |
| -General & Admin Expense | €3.73B | €3.54B | €3.63B | €12.02B | €3.58B |
| Depreciation & Amortization & Depletion | €434.00M | €416.00M | €418.00M | €1.52B | €393.00M |
| -Depreciation & Amortization | €434.00M | €416.00M | €418.00M | €1.52B | €393.00M |
| Other Non-Interest Expenses | €37.00M | €722.00M | €64.00M | €1.43B | €140.00M |
| Other Income (Expense) | -€16.00M | €26.00M | €2.00M | -€873.00M | -€4.00M |
| Special Income (Charges) | -€16.00M | -€3.00M | €2.00M | -€935.00M | -€4.00M |
| -Less:Other Special Charges | €16.00M | -€12.00M | -€2.00M | €955.00M | €4.00M |
| Pretax Profit | €4.74B | €4.86B | €4.72B | €16.23B | €3.93B |
| Tax | €1.54B | €1.58B | €1.53B | €5.10B | €1.27B |
| Net Profit | €3.20B | €3.28B | €3.19B | €11.13B | €2.67B |
| Profit from Continuing Operations | €3.20B | €3.28B | €3.19B | €11.13B | €2.67B |
| Minority Interests | €188.00M | €219.00M | €199.00M | €615.00M | €132.00M |
| Net Income to Parent Company | €3.02B | €3.06B | €2.99B | €10.51B | €2.53B |
| Net Income to Common Stockholders | €3.02B | €3.06B | €2.88B | €10.11B | €2.53B |
| Basic EPS | €0.52 | €0.53 | €0.51 | €1.76 | €0.42 |
| Diluted EPS | €0.52 | €0.53 | €0.51 | €1.76 | €0.42 |
| Dividend Per Share | €0.00 | €0.61 | €0.00 | €0.72 | €0.32 |
| -Interest Expense | – | €8.88B | – | €32.07B | – |
| -Total Premiums Earned | – | €472.00M | – | €1.52B | – |
| -Dividend Income | – | €62.00M | – | €123.00M | – |
| -Foreign Exchange Trading Gains | – | -€111.00M | – | -€285.00M | – |
| Income from Associates & Other Participating Interests | – | €29.00M | – | €62.00M | – |
| -Less:Restructuring and Mergern & Acquisition | – | €0.00 | – | €0.00 | – |
| -Less:Impairment of Capital Assets | – | €2.00M | – | €9.00M | – |
| -Less:Write Off | – | €1.00M | – | €7.00M | – |
| Net Income from Discontinuous Operations | – | €0.00 | – | €0.00 | – |
| Other Preferred Stock Dividends | – | – | €113.00M | €397.00M | – |
| Occupancy and Equipment | – | – | – | €561.00M | – |
| -Selling & Marketing Expense | – | – | – | €564.00M | – |
| -Gain on Sale of Business | – | – | – | €36.00M | – |
Balance sheet
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €986.19B | €965.43B | €894.27B | €859.58B | €859.58B |
| Cash, Cash Equivalents & Federal Funds Sold | €107.95B | €151.78B | €80.12B | €125.96B | €125.96B |
| -Cash and Cash Equivalents | €107.95B | €76.48B | €80.12B | €69.89B | €69.89B |
| Securities Investment | €307.85B | €197.09B | €293.51B | €184.22B | €184.22B |
| -Trading Securities | €154.54B | €48.52B | €144.30B | €40.75B | €40.75B |
| -Available for Sale Securities | €93.57B | €87.11B | €87.27B | €85.12B | €85.12B |
| -Short Term Investments | €59.74B | €61.46B | €61.94B | €58.36B | €58.36B |
| Long Term Equity Investment | €981.00M | €997.00M | €1.02B | €994.00M | €994.00M |
| Net Loan | €527.46B | €524.54B | €478.95B | €468.84B | €468.84B |
| -Gross Loan | €540.77B | €537.66B | €491.62B | €481.13B | €481.13B |
| -Allowance for Loans and Lease Losses | €13.31B | €13.12B | €12.67B | €12.30B | €12.30B |
| Net PPE | €9.76B | €9.52B | €9.67B | €9.25B | €9.25B |
| Goodwill and Other Intangible Assets | €3.20B | €3.12B | €2.94B | €2.86B | €2.86B |
| Other Assets | €29.00B | €3.37B | €28.07B | €3.14B | €3.14B |
| Total Liabilities | €923.62B | €901.64B | €833.46B | €797.78B | €797.78B |
| Total Deposits | €539.56B | €535.97B | €505.06B | €513.01B | €513.01B |
| Trading Liabilities | €171.20B | €49.86B | €151.20B | €24.62B | €24.62B |
| Long Term Debt and Capital Lease Obligation | €110.87B | €112.96B | €87.56B | €89.08B | €89.08B |
| -Long Term Debt | €110.87B | €112.96B | €87.56B | €87.84B | €87.84B |
| Other Liabilities | €101.99B | €34.10B | €89.64B | €29.60B | €29.60B |
| Total Equity | €62.57B | €63.79B | €60.80B | €61.80B | €61.80B |
| Stockholders' Equity | €57.57B | €58.95B | €56.27B | €57.36B | €57.36B |
| Capital Stock | €75.26B | €2.74B | €74.80B | €2.80B | €2.80B |
| -Common Stock | €75.26B | €2.74B | €74.80B | €2.80B | €2.80B |
| Gains/Losses Not Affecting Retained Earnings | -€17.69B | -€17.26B | -€18.53B | -€20.51B | -€20.51B |
| Minority Interests | €4.99B | €4.84B | €4.53B | €4.44B | €4.44B |
| -Money Market Investments | – | €75.30B | – | €56.08B | €56.08B |
| Derivative Assets | – | €39.39B | – | €33.03B | €33.03B |
| Receivables | – | €16.60B | – | €16.71B | €16.71B |
| -Other Receivables | – | €16.60B | – | €16.71B | €16.71B |
| -Gross PPE | – | €18.19B | – | €17.26B | €17.26B |
| -Accumulated Depreciation | – | -€8.67B | – | -€8.01B | -€8.01B |
| -Goodwill | – | €767.00M | – | €715.00M | €715.00M |
| -Other Intangible Assets | – | €2.36B | – | €2.14B | €2.14B |
| Deferred Assets | – | €14.15B | – | €13.87B | €13.87B |
| Assets Held for Sale | – | €4.86B | – | €709.00M | €709.00M |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | – | €115.09B | – | €79.08B | €79.08B |
| Derivative Product Liabilities | – | €38.26B | – | €32.28B | €32.28B |
| Payables | – | €1.69B | – | €20.28B | €20.28B |
| -Total Tax Payable | – | €1.69B | – | €1.48B | €1.48B |
| Current Accrued Expenses | – | €3.67B | – | €3.46B | €3.46B |
| Non-Current Liabilities | – | €1.08B | – | €1.02B | €1.02B |
| Employee Benefits | – | €2.50B | – | €2.60B | €2.60B |
| Non-Current Deferred Liabilities | – | €3.00B | – | €2.54B | €2.54B |
| Liabilities of Discontinued Operations | – | €3.46B | – | €0.00 | €0.00 |
| Additional Paid-In Capital | – | €16.95B | – | €18.47B | €18.47B |
| Retained Earnings | – | €57.49B | – | €56.86B | €56.86B |
| Less: Treasury Stock | – | €990.00M | – | €299.00M | €299.00M |
| Other Equity Interests | – | €33.00M | – | €40.00M | €40.00M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | €227.00M | €227.00M |
| -Current Capital Lease Obligation | – | – | – | €227.00M | €227.00M |
| -Other Payable | – | – | – | €18.80B | €18.80B |
| -Long Term Capital Lease Obligation | – | – | – | €1.24B | €1.24B |
Cash flow
| Line item | 2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
2024 ANNUAL (EUR) |
2024 Q4 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | €14.97B | €4.01B | €17.17B | -€18.19B | -€6.70B |
| Net cash flow from continuing operations | €14.97B | €4.01B | €17.17B | -€18.19B | -€6.70B |
| Net Income from Continuing Operations | €11.13B | €2.67B | €2.66B | €10.58B | €2.59B |
| Depreciation & Depletion & Amortization | €1.52B | €393.00M | €379.00M | €1.53B | €408.00M |
| Other Non-Cash Items | €12.85B | €5.05B | €1.56B | €13.28B | €12.84B |
| Change in Working Capital | -€7.21B | -€2.60B | €13.48B | -€37.95B | -€20.62B |
| -Change in Other Current Assets | €672.00M | – | – | -€2.14B | – |
| -Change in Other Current Liabilities | -€1.35B | – | – | €392.00M | – |
| -Change in Other Working Capital | -€6.53B | -€1.92B | €14.82B | -€36.20B | -€18.87B |
| Net cash flow from investing | -€1.40B | -€478.00M | -€379.00M | -€1.42B | -€257.00M |
| Net Cash Flow from Continuing Investing Activities | -€1.40B | -€478.00M | -€379.00M | -€1.42B | -€257.00M |
| Net PPE Purchase and Sale | -€744.00M | -€321.00M | -€191.00M | -€1.09B | -€246.00M |
| Net Intangibles Purchase and Sale | -€979.00M | -€297.00M | -€245.00M | -€816.00M | -€293.00M |
| Net Business Purchase and Sale | €50.00M | €50.00M | €0.00 | €45.00M | €68.00M |
| Net Investment Purchase and Sale | €82.00M | €38.00M | €3.00M | €31.00M | €10.00M |
| Net Other Investing Changes | €188.00M | €52.00M | €54.00M | €408.00M | €204.00M |
| Financing Cash Flow | -€3.67B | -€1.79B | €278.00M | -€2.57B | -€1.13B |
| Net Cash Flow from Continuing Financing Activities | -€3.67B | -€1.79B | €277.00M | -€2.57B | -€1.13B |
| Net Issuance Payments of Debt | €2.34B | €1.33B | €335.00M | €2.92B | €601.00M |
| Net Common Stock Issuance | -€1.24B | -€1.18B | €2.00M | -€838.00M | €41.00M |
| Cash Dividends Paid | -€4.20B | -€1.84B | €0.00 | -€3.91B | -€1.67B |
| Net Other Financing Activities | -€579.00M | -€104.00M | -€59.00M | -€731.00M | -€105.00M |
| Ending Cash Balance | €58.84B | €58.84B | €57.13B | €51.15B | €51.15B |
| Net Change in Cash | €9.89B | €1.74B | €17.07B | -€22.18B | -€8.09B |
| Beginning Cash Balance | €51.15B | €57.13B | €40.02B | €75.42B | €58.59B |
| Effect of Exchange Rate Changes | -€2.20B | -€25.00M | €40.00M | -€2.09B | €645.00M |
| Free Cash Flow | €13.16B | €3.31B | €16.75B | -€20.20B | -€7.34B |
No comments yet — be the first to weigh in on BBVA.
Sign in to join the discussion.